Vous avez cherché: addition of new reference (Danois - Néerlandais)

training of new staff
training of new staff

clinical investigation of new vaccines
clinical investigation of new vaccines

b01ac16 prevention of new myocardial infarction
b01ac16 prevention of new myocardial infarction

harmonisation of requirements for equine influenza vaccines specific requirements for substitution or addition of a strain
harmonisation of requirements for equine influenza vaccines specific requirements for substitution or addition of a strain

guideline for the photostability testing of new drug substances and products
guideline for the photostability testing of new drug substances and products

note for guidance on stability testing of new drug substances and products step 2 document
note for guidance on stability testing of new drug substances and products step 2 document

this amendment introduced the phasing out of aid for construction of new fishing vessels.
this amendment introduced the phasing out of aid for construction of new fishing vessels.

annex to note for guidance on stability testing of new active substances and medicinal products.
annex to note for guidance on stability testing of new active substances and medicinal products.

guidelines clinical investigation of new vaccines modified release oral and transdermal dosage forms:
richtsnoeren clinical investigation of new vaccines modified release oral and transdermal dosage forms:

research foundation of state university of new york (rfsuny), albany, usa
the research foundation of state university of new york (rfsuny), albany, verenigde staten van amerika

banken, der først hed city bank of new york, blev senere på grund af sin udvikling og ekspansion kaldet citibank.
de oorspronkelijke naam city bank of new york werd later gewijzigd in citibank wegens de evolutie en uitbreiding ervan.

concept paper on the development of a cpmp points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections
concept paper on the development of a cpmp points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections

department of political science, baruch college, city university of new york (staten new york, usa)
department of political science, baruch college, new york city university (staat new york, verenigde staten van amerika)

det skal i denne forbindelse understreges, at banknavnet citibank oprindeligt var city bank of new york, og at sagsøgerne ofte bruger deres varemærke the citi never sleeps.
op dit punt dient met klem erop te worden gewezen dat de naam van de bank citibank oorspronkelijk city bank of new york was en dat verzoeksters vaak gebruikmaken van hun merk the citi never sleeps.

(') »study on the possibilities for the replacement of lead in gasoline by the addition of compounds«, undersøgelse foretaget af chem systems international ltd. for kommissionen for de europæiske fællesskaber.
onderzoek uitgevoerd door chem systèmes international ltd. voor de commissie van de europese gemeenschappen.

points to consider on the clinical investigation of new medicinal products for treatment of acute coronary syndrome (acs) without persistent st- segment elevation
treatment of acute coronary syndrome (acs) without persistent st-segment elevation concept paper on the development of a cpmp note for guidance on the clinical

(27) under the scheme aid has been granted to improve fish factories for the purchase of new processing machinery and equipment and for the construction, improvement or extension of fish factories.
(27) under the scheme aid has been granted to improve fish factories for the purchase of new processing machinery and equipment and for the construction, improvement or extension of fish factories.

på engelsk butter for concentration and the addition of tracers for use in accordance with article 6(1)(a) of regulation (ec) no 1898/2005
engels butter for concentration and the addition of tracers for use in accordance with article 6(1)(a) of regulation (ec) no 1898/2005

adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow- acting anti- rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
adjustment for multiplicity and related topics points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications: adjustment for baseline covariates points to consider on clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications: